Search Results 561-570 of 15626 for pharmacogenetics
Mayo Clinic Research Core Facilities: Molecular development cores produce monoclonal and polyclonal antibodies and transgenic and knockout mice.
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...
The purpose of this study is to evaluate the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in 2 groups of patients with peritoneal ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
About this study. The purpose of this biobank is to develop a research resource for bipolar disorder. Patients, and close genetic relatives, will provide ...
Giudicessi, John R. M.D., Ph.D. giudicessi.john@mayo.edu; Assistant Professor of Pharmacology; Assistant Professor of Medicine. Goetz, Matthew P. M.D..
Jacksonville, Fla. This study will collect and store samples of tissue and blood for current and future research studies on Liver and Biliary Tumors. Registry ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.